semaglutide maker Wegovy ends partnership with Hims & Hers Ozempic maker sets clinical trial

This emerging metabolic-psychiatry approach offers hope for a population often left without effective options

Vials are available in 5 mg and 12.5 mg options

Those in the very highest percentile of Lp(a) levels had a raised risk of ischemic stroke and cardiovascular death, the researchers reported in JAMA Cardiology

It does not increase thermogenesis (heat production) or significantly elevate resting energy expenditure in humans

The loss of butyrate-producing bacteria initiates a devastating vicious cycle

The 2021 prelude presentation of the STEP1 trial examined semaglutide weekly in adults with overweight BMI plus a comorbidity or with obesity and no comorbid condition